Brind.

Pfizer, BioNTech, Merck KGaA, and Moderna announced joint developments regarding Comirnaty and a new cancer treatment.

1 report, 1 independent Updated Sep 2

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Pfizer Merck KGaA Moderna

Keep exploring

The entities involved

Pfizer
American multinational pharmaceutical and biotechnology corporation
- University of Hyderabad is hosting a drug discovery program featuring scientists from Pfizer and Bristol-Myers Squibb in Hyderabad.16:43
- RBC raised its rating on Pfizer stock, and HSBC also raised its target price for the company.03:31
Merck KGaA
German multinational science and technology company
- Moderna announced a collaboration with Merck KGaA regarding a personalized cancer vaccine platform.14:14
- Evaxion will present clinical trial data at the ESMO Congress 2025 in Berlin, utilizing therapy from Merck Sharp & Dohme.09:00
Moderna
American biotechnology company
- Moderna and Merck announced a partnership on their mRNA cancer vaccine trial, leading to analyst rating hikes.18:27
- Moderna presented vaccine results at the ESMO meeting in Madrid, with RBC Capital Markets covering the company.10:55

Related events

Coverage

Newest first; wire copies grouped

Sep 2fool.com